Sichuan Historical Cash Flow
| 603077 Stock | 2.04 0.01 0.49% |
Analysis of Sichuan Hebang cash flow over time is an excellent tool to project Sichuan Hebang Biote future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Dividends Paid of 486.8 M or Capital Expenditures of 767.6 M as it is a great indicator of Sichuan Hebang ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Sichuan Hebang Biote latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Sichuan Hebang Biote is a good buy for the upcoming year.
Sichuan |
About Sichuan Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Sichuan balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Sichuan's non-liquid assets can be easily converted into cash.
Sichuan Hebang Cash Flow Chart
Add Fundamental
Capital Expenditures
Capital Expenditures are funds used by Sichuan Hebang Biote to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Sichuan Hebang operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Net Income
Net income is one of the most important fundamental items in finance. It plays a large role in Sichuan Hebang Biote financial statement analysis. It represents the amount of money remaining after all of Sichuan Hebang Biotechnology operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Change To Inventory
The increase or decrease in the amount of inventory a company has over a certain period.Investments
Securities or assets acquired for generating income or appreciating in value, not used in daily operations.Most accounts from Sichuan Hebang's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Sichuan Hebang Biote current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Sichuan Hebang Biotechnology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. At present, Sichuan Hebang's Other Cashflows From Financing Activities is projected to decrease significantly based on the last few years of reporting. The current year's Dividends Paid is expected to grow to about 486.8 M, whereas Capital Expenditures is forecasted to decline to about 767.6 M.
| 2021 | 2022 | 2023 | 2024 (projected) | Capital Expenditures | 1.8B | 936.2M | 828.7M | 767.6M | Dividends Paid | 78.0M | 197.8M | 463.6M | 486.8M |
Sichuan Hebang cash flow statement Correlations
Click cells to compare fundamentals
Sichuan Hebang Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Sichuan Hebang cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Other Cashflows From Financing Activities | (239.7M) | 6.0M | 458.0M | 760.5M | 684.5M | 718.7M | |
| Dividends Paid | 71.1M | 92.7M | 78.0M | 197.8M | 463.6M | 486.8M | |
| Capital Expenditures | 662.5M | 197.1M | 1.8B | 936.2M | 828.7M | 767.6M | |
| Total Cash From Operating Activities | 162.9M | 368.9M | 3.3B | 2.6B | 80.3M | 76.3M | |
| Net Income | 516.9M | 40.9M | 3.0B | 3.8B | 1.3B | 862.7M | |
| Total Cash From Financing Activities | 367.1M | 78.4M | (619.4M) | 1.0B | 904.5M | 949.7M | |
| Other Cashflows From Investing Activities | 84.6M | 40.1M | 10.1M | 4.2M | 3.8M | 3.6M | |
| Change To Inventory | (269.2M) | 678.3M | (278.9M) | (1.2B) | (2.3B) | (2.2B) | |
| Investments | (55.3M) | (56.0M) | (15.8M) | 57.8M | (782.2M) | (743.1M) | |
| Change In Cash | (737.1M) | 263.1M | 844.3M | 2.9B | (1.6B) | (1.6B) | |
| Net Borrowings | 677.8M | 285.2M | (819.5M) | 442.3M | 508.6M | 534.1M | |
| Total Cashflows From Investing Activities | (1.3B) | (210.4M) | (1.8B) | (807.2M) | (928.3M) | (974.7M) | |
| Depreciation | 635.6M | 643.0M | 643.9M | 929.5M | 1.0B | 696.1M | |
| Change To Account Receivables | (305.9M) | (468.3M) | 29.8M | (1.1B) | (974.8M) | (926.0M) | |
| Change To Netincome | 73.7M | 46.8M | 71.8M | 84.4M | 97.1M | 81.7M | |
| Change To Liabilities | (489.2M) | (574.2M) | (215.8M) | 83.9M | 75.5M | 79.3M | |
| End Period Cash Flow | 573.5M | 836.7M | 1.7B | 4.5B | 2.9B | 1.8B | |
| Free Cash Flow | (499.6M) | 171.8M | 1.5B | 1.7B | (748.4M) | (711.0M) | |
| Change In Working Capital | (1.1B) | (316.3M) | (543.5M) | (2.2B) | (2.2B) | (2.1B) | |
| Begin Period Cash Flow | 1.3B | 573.5M | 836.7M | 1.7B | 4.5B | 4.8B | |
| Other Non Cash Items | 60.8M | 117.5M | 93.7M | 47.4M | 27.5M | 26.1M |
Currently Active Assets on Macroaxis
Other Information on Investing in Sichuan Stock
The Cash Flow Statement is a financial statement that shows how changes in Sichuan balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Sichuan's non-liquid assets can be easily converted into cash.